Neurochemical and behavioral consequences of striatal injection of 5,7-dihydroxytryptamine

Journal of Neuroscience Methods

Volumn 162, Issue 1-2, 2007, Pages 108-118

  Ludwig, Verena ^a   Schwarting, Rainer K W ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

5,7 Dihydroxytryptamine; Amygdala; Anxiety; Avoidance; Dopamine; Elevated plus maze; Frontal cortex; Locomotion; MDMA; Neostriatum; Nomifensine; Serotonin; Ultrasonic vocalization; Ventral striatum

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; NEUROTOXIN; NOMIFENSINE; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; FOREBRAIN; FRONTAL CORTEX; MALE; NEOSTRIATUM; NEUROCHEMISTRY; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; VOCALIZATION;

5,7-DIHYDROXYTRYPTAMINE; AMYGDALA; ANIMALS; CORPUS STRIATUM; DOPAMINE; EQUIPMENT DESIGN; FRONTAL LOBE; HYDROXYINDOLEACETIC ACID; MALE; MAZE LEARNING; RATS; RATS, WISTAR; SEROTONIN;

EID: 34047119555     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2006.12.011     Document Type: Article

References (66)

1. Ando R.D., Benko A., Ferrington L., Kirilly E., Kelly P.A.T., and Bagdy G. Partial lesion of the 5HT system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 50 (2006) 884-896
2. Andrade T.G.C.S., and Graeff F.G. Effect of electrolytic and neurotoxic lesions of the median raphé nucleus on anxiety and stress. Pharmacol Biochem Behav 70 (2001) 1-14
3. Baumgarten H.G., and Lachenmayer L. 5,7-Dihydroxytryptamine: improvement in chemical lesioning of indoleamine neurons in the mammalian brain. Z Zellforsch 135 (1972) 399-414
4. Baumgarten H.G., and Lachenmayer L. Serotonin neurotoxins-past and present. Neurotoxicity Res 6 (2004) 589-614
5. Björklund A., Horn A.S., Baumgarten H.G., Nobin A., and Schlossberger H.G. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 2. In vitro studies on monoamine uptake inhibition and uptake impairment. Acta Physiol Scand 429 (1975) 29-60
6. Blanchard R.J., Blanchard D.C., Agulla R., and Weiss S. Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiol Behav 50 (1991) 967-972
7. Bland S.T., Schmid M.J., Watkins L.R., and Maier S.F. Prefrontal cortex serotonin, stress, and morphine-induced nucleus accumbens dopamine. Neuroreport 15 (2004) 2637-2641
8. Borta A., Wöhr M., and Schwarting R.K.W. Rat ultrasonic vocalization in aversively motivated situations and the role of individual differences in anxiety-related behavior. Behav Brain Res 166 (2006) 271-280
9. Brennan K.A., and Schenk S. Initial deficit and recovery of function after MDMA preexposure in rats. Psychopharmacology 184 (2006) 239-246
10. Briley M., Chopin P., and Moret C. Effect of serotonergic lesion on "anxious" behaviour measured in the elevated plus-maze test in the rat. Psychopharmacology 101 (1990) 187-189
11. Bures J., Buresova O., and Huston J.P. Techniques and Basic Experiments for the Study of Brain and Behavior (1983), Elsevier Science Publishers, Amsterdam p. 256
12. Carter C.J., and Pycock C.J. The effects of 5,7-dihydroxytryptamine lesions of extrapyramidal and mesolimbic sites on spontaneous motor behavior, and amphetamine-induced stereotypy. Naunyn-Schmiedeberg's Arch Pharmacol 308 (1979) 51-54
13. Chia L.-G., Ni D.-R., Cheng F.-C., Ho Y.-P., and Kuo J.-S. Intrastriatal injection of 5,7-dihydroxytryptamine decreased 5-HT levels in the striatum and suppressed locomotor activity in C57BL/6 Mice. Neurochem Res 24 (1999) 719-722
14. Choi S., Jonak E., and Ferrari P.F. Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain. Brain Res 1007 (2004) 19-28
15. Cole J.C., and Sumnall H.R. The preclinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 27 (2003) 199-217
16. Dawson G.R., Crawford S.P., Stanhope K.J., Iverson S.D., and Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology 113 (1994) 570-572
17. Dawson G.R., and Tricklebank M.D. Use of the elevated plus-maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16 (1995) 33-36
18. Deakin J.W., and Graeff F.G. 5-HT and mechanisms of defense. J Psychopharmacol 5 (1991) 305-315
19. De Vry J., Benz U., Schreiber R., and Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol 249 (1993) 331-339
20. Fendt M., and Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci Biobehav Rev 23 (1999) 743-760
21. Ferre S., Cortes R., and Artigas F. Dopaminergic regulation of the serotonergic raphé-striatal pathway-microdialysis studies in freely moving rats. J Neurosci 14 (1994) 4839-4846
22. File S.E., Gonzalez L.E., and Andrews N. Comparative study of pre- and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 16 (1996) 4810-4815
23. File S.E., Zangrossi H., Viana M.B., and Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear?. Psychopharmacology 111 (1993) 491-494
24. Fletcher P.J., Korth K.M., and Chambers J.W. Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacology 147 (1999) 291-299
25. Gurtman C.G., Morley K.C., Li K.M., Hunt G.E., and McGregor I.S. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol 446 (2002) 89-96
26. Hall C.S. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 18 (1934) 385-403
27. Hall F.S., DeVries A.C., Fong G.W., Huang S., and Pert A. Effects of 5,7-dihydroxytryptamine depletion of tissue serotonin levels on extracellular serotonin in the striatum assessed with in vivo microdialysis: relationship to behavior. Synapse 33 (1999) 16-25
28. Handley S.L. 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacol Ther 66 (1995) 103-148
29. Handley S.L., and McBlane J.W. 5-HT drugs in animal models of anxiety. Psychopharmacology 112 (1993) 13-20
30. Harro J., Tonissaar M., Eller M., Kask A., and Oreland L. Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry. Brain Res 899 (2001) 227-239
31. Hefti F., Melamed E., Sahakian B.J., and Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Pharmacol Biochem Behav 12 (1980) 185-188
32. Heimer L., Zahm D.S., Churchill L., Kalivas P.W., and Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41 (1991) 89-125
33. Ho Y.-J., Eichendorff J., and Schwarting R.K.W. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 136 (2002) 1-12
34. Ho Y.-J., Pawlak C.R., Guo L., and Schwarting R.K.W. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res 149 (2004) 135-144
35. Iverson S.D. 5-HT and anxiety. Neuropharmacology 23 (1984) 1553-1560
36. Jelen P., Soltysik S., and Zagrodzka J. 22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state. Behav Brain Res 141 (2003) 63-72
37. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat ?. J Pharmacol Exp Ther 272 (1995) 920-929
38. Kehne J.H., Ketteler H.J., McCloskey T.C., Sullivan C.K., Dudley M.W., and Schmidt C.J. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacology 15 (1996) 116-124
39. Knutson B., Burgdorf J., and Panksepp J. Ultrasonic vocalizations as indices of affective states in rats. Psychol Bull 128 (2002) 961-977
40. Lehmann O., Jeltsch H., Lehnardt O., Pain L., Lazarus C., and Cassel J.C. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization. Eur J Neurosci 12 (2000) 67-79
41. Lowry C.A., Johnson P.L., Hay-Schmidt A., Mikkelsen J., and Shekhar A. Modulation of anxiety circuits by serotonergic systems. Stress 8 (2005) 233-246
42. Lyles J., and Cadet J.L. Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Rev 42 (2003) 155-168
43. Mobini S., Chiang T.J., Ho M.Y., Bradshaw C.M., and Szabadi E. Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement. Psychopharmacology 152 (2000) 390-397
44. Netto S.M., Silveira R., Coimbra N.C., Joca S.R.L., and Guimaraes F.S. Anxiogenic effect of median raphé nucleus lesion in stressed rats. Prog Neuropsychopharmacol Biol Psych 26 (2002) 1135-1141
45. Olausson P., Akesson P., Petersson A., Engel J.A., and Soderpalm B. Behavioral and neurochemical consequences of repeated nicotine treatment in the serotonin-depleted rat. Psychopharmacology 155 (2001) 348-361
46. Otano A., Frechilla D., Cobreros A., Cruz-Orive L.M., Insausti A., Insausti R., et al. Anxiogenic-like effects and reduced stereological counting of immunolabelled 5-hydroxytryptamine(6) receptors in rat nucleus accumbens by antisense oligonucleotides. Neuroscience 92 (1999) 1001-1009
47. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, Orlando
48. Phelix C.F., and Broderick P.A. Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res Bull 37 (1995) 37-40
49. Prut L., and Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463 (2003) 3-33
50. Rex A., Marsden C.A., and Fink H. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze. Psychopharmacology 110 (1993) 490-496
51. Rex A., Thomas H., Hortnagl H., Voits M., and Fink H. Behavioural and microdialysis study after neurotoxic lesion of the dorsal raphé nucleus in rats. Pharmacol Biochem Behav 74 (2003) 587-593
52. Rodgers R.J., Cao B.J., Dalvi A., and Holmes A. Animal models of anxiety: an ethological perspective. Brazilian J Med Biol Res 30 (1997) 289-304
53. Rodgers R.J., and Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plusmaze and light/dark tests of anxiety in mice. Psychopharmacology 113 (1993) 237-242
54. Sanchez C. Stress-induced vocalisation in adult animals. A valid model of anxiety?. Eur J Pharmacol 463 (2003) 133-143
55. Schwarting R.K.W., and Carey R.J. Deficits in inhibitory avoidance after neurotoxic lesions of the ventral striatum are neurochemically and behaviourally selective. Behav Brain Res 18 (1985) 279-283
56. Schwarting R.K.W., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
57. Schwarting R.K.W., and Pawlak C.R. Behavioral neuroscience in the rat: taking the individual into account. Meth Find Exp Clin Pharmacol 26 (2004) 17-22
58. Schwarting R.K.W., Thiel C.M., Müller C.P., and Huston J.P. Relationship between anxiety and serotonin in the ventral striatum. Neuroreport 9 (1998) 1025-1029
59. Sommer W., Moller C., Wiklund L., Thorsell A., Rimondrini R., Nissbrandt H., et al. Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology 24 (2001) 430-440
60. Spoont M.R. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol Bull 112 (1992) 330-350
61. Suarez-Roca H., and Cubeddu L.X. The selective serotonin reuptake inhibitor citalopram induces the storage of serotonin in catecholaminergic terminals. J Pharmacol Exp Ther 302 (2002) 174-179
62. Thomas H., Fink H., Sohr R., and Voits M. Lesion of the median raphé nucleus: a combined behavioral and microdialysis study in rats. Pharmacol Biochem Behav 65 (2000) 15-21
63. Treit D., and Fundyus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol Biochem Behav 31 (1989) 959-962
64. van der Poel A.M., and Miczek K.A. Long ultrasonic calls in male rats following mating, defeat and aversive stimulation: frequency modulation and bout structure. Behaviour 119 (1991) 127-142
65. Wöhr M., Borta A., and Schwarting R.K.W. Overt behavior and ultrasonic vocalization in a fear conditioning paradigm: a dose-response study in the rat. Neurobiol Learn Mem 84 (2005) 228-240
66. Zangrossi H., and Graeff F.G. Behavioral effects of intraamygdala injections of GABA and 5-HT acting drugs in the elevated plus-maze. Brazilian J Med Biol Res 27 (1994) 2453-2456